Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-23 7:55 pm Purchase | 2025-03-31 | 13G | AstraZeneca PLC AZN | BlackRock Inc. BLK | 117,761,076 7.600% | 36,415,256 (+44.77%) | Filing History |
| 2025-04-10 06:00 am Sale | 2025-03-31 | 13G | CDT Equity Inc. CDT | ASTRAZENECA PLC | 616 1.100% | -176 (-22.26%) | Filing History |
| 2025-01-24 09:52 am Purchase | 2025-01-23 | 13D | Cellectis S.A. CLLS | ASTRAZENECA PLC | 44,000,000 44.000% | 28,000,000 (+175.00%) | Filing History |
| 2024-10-28 06:00 am Purchase | 2024-10-23 | 13G | Monopar Therapeutics Inc. MNPR | ASTRAZENECA PLC | 387,329 9.900% | 387,329 (New Position) | Filing History |
| 2024-10-11 06:01 am Purchase | 2024-08-07 | 13G | CDT Equity Inc. CDT | ASTRAZENECA PLC | 792 9.900% | 792 (New Position) | Filing History |
| 2024-02-12 10:13 am Unchanged | 2023-12-31 | 13G | ADC Therapeutics S.A. ADCT | ASTRAZENECA PLC | 4,011,215 4.880% | 0 (Unchanged) | Filing History |
| 2024-01-24 5:23 pm Sale | 2023-12-31 | 13G | AstraZeneca PLC AZN | BlackRock Inc. BLK | 140,325,832 9.100% | -8,700,570 (-5.84%) | Filing |
| 2023-11-16 11:16 am Unchanged | 2023-11-14 | 13D | Cellectis S.A. CLLS | ASTRAZENECA PLC | 16,000,000 22.400% | 0 (Unchanged) | Filing History |
| 2023-11-09 5:07 pm Purchase | 2023-11-01 | 13D | Cellectis S.A. CLLS | ASTRAZENECA PLC | 16,000,000 22.400% | 16,000,000 (New Position) | Filing History |
| 2023-02-10 10:25 am Unchanged | 2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | ASTRAZENECA PLC | 884,956 3.400% | 0 (Unchanged) | Filing History |
| 2023-02-10 10:22 am Unchanged | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | ASTRAZENECA PLC | 44,803 4.800% | 0 (Unchanged) | Filing History |
| 2023-01-24 1:56 pm Sale | 2022-12-31 | 13G | AstraZeneca PLC AZN | BlackRock Inc. BLK | 149,026,402 9.600% | -8,364,904 (-5.31%) | Filing |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | AstraZeneca PLC AZN | BlackRock Inc. BLK | 157,391,306 10.200% | 18,458,884 (+13.29%) | Filing |
| 2022-02-07 4:33 pm Purchase | 2021-12-31 | 13G | AstraZeneca PLC AZN | BlackRock Inc. BLK | 138,932,422 9.000% | 23,755,621 (+20.63%) | Filing |
| 2022-02-04 09:06 am Sale | 2021-12-31 | 13G | AstraZeneca PLC AZN | Wellington Management Group LLP | 65,542,362 4.230% | -2,982,967 (-4.35%) | Filing History |
| 2021-07-27 1:20 pm Purchase | 2021-07-20 | 13G | Aridis Pharmaceuticals, Inc. ARDS | ASTRAZENECA PLC | 884,956 7.300% | 884,956 (New Position) | Filing History |
| 2021-04-07 5:37 pm Purchase | 2021-04-01 | 13G | Pieris Pharmaceuticals, Inc. PIRS | ASTRAZENECA PLC | 44,803 5.660% | 44,803 (New Position) | Filing History |
| 2021-02-10 4:01 pm Purchase | 2020-05-11 | 13G | ADC Therapeutics S.A. ADCT | ASTRAZENECA PLC | 4,011,215 5.230% | 4,011,215 (New Position) | Filing History |
| 2021-02-10 4:01 pm Sale | 2020-12-31 | 13G | Moderna, Inc. MRNA | ASTRAZENECA PLC | 0 0.000% | -25,499,325 (Position Closed) | Filing History |
| 2021-02-03 1:13 pm Sale | 2020-12-31 | 13G | AstraZeneca PLC AZN | Wellington Management Group LLP | 68,525,329 5.220% | -8,978,560 (-11.58%) | Filing History |